Endoscopic Ultrasound Needles

Endoscopic Ultrasound Needles Market Outlook

The global endoscopic ultrasound needles market was estimated to be valued at approximately USD 450 million in 2023, with a projected compound annual growth rate (CAGR) of 5.8% from 2025 to 2035. This growth can primarily be attributed to the increasing prevalence of gastrointestinal disorders and the rising demand for minimally invasive procedures. Additionally, advancements in endoscopic technologies and the growing emphasis on early diagnosis and treatment of various diseases have further driven market growth. Moreover, a notable rise in healthcare expenditure globally is facilitating the adoption of advanced medical devices, thereby propelling the endoscopic ultrasound needles market. The aging population, which is more susceptible to chronic conditions requiring endoscopic interventions, is an additional contributing factor to the market expansion.

Growth Factor of the Market

Several factors are propelling the growth of the endoscopic ultrasound needles market. The increasing incidence of cancers, specifically gastroenterological malignancies, has led to a surge in demand for accurate and effective diagnostic tools, including endoscopic ultrasound needles. Furthermore, the rising preference for minimally invasive procedures is encouraging healthcare providers to adopt advanced endoscopic technology, fostering market growth. Innovations in needle design, such as the development of specialized biopsy needles that enhance tissue sampling capabilities, are also significant growth drivers. Additionally, the integration of imaging technologies with endoscopy is improving the precision of diagnoses, further supporting market expansion. The global focus on improving healthcare infrastructure and increasing access to quality medical care, particularly in emerging economies, is also a crucial factor contributing to the market’s robust growth trajectory.

Key Highlights of the Market

• Expected growth to reach approximately USD 750 million by 2035, driven by technological advancements.
• High demand for minimally invasive procedures is reshaping the market landscape.
• North America is the leading region, accounting for a significant share of the market.
• Biopsy needles are expected to dominate the product segment due to increasing cancer diagnoses.
• Hospitals remain the primary end-user, leveraging advanced endoscopic technologies for patient care.

By Product Type

Fine Aspiration Needles:

Fine aspiration needles (FANs) are widely used in endoscopic ultrasound procedures for sampling cellular material from various organs. These needles are specifically designed for high-precision aspiration of tissue, allowing for accurate cytological diagnosis. The increasing incidence of tumors, particularly in the pancreas and thyroid, has driven demand for fine aspiration needles, as they provide a less invasive option compared to traditional surgical biopsy methods. In addition, innovations in needle tip design have enhanced the performance of FANs, making them more efficient in obtaining samples. The fine aspiration needle segment is projected to experience robust growth, as healthcare professionals increasingly recognize the advantages of using these needles in diagnostic procedures. Furthermore, the rising emphasis on early disease detection, especially in oncology, is expected to bolster the market for fine aspiration needles significantly.

Biopsy Needles:

Biopsy needles are critical tools in the endoscopic ultrasound landscape, specifically designed for obtaining tissue samples from suspicious lesions. These needles offer superior control and precision in targeting lesions, making them essential for accurate histopathological analysis. The segment is expected to dominate the market due to the rising global incidence of cancers, which necessitates accurate tissue diagnosis for effective treatment planning. Additionally, advancements in biopsy needle designs, such as larger gauge sizes and innovative cutting mechanisms, are enhancing the efficiency and effectiveness of tissue sampling. The increasing number of endoscopic procedures, along with the growing awareness of the benefits of early cancer detection, is further driving the demand for biopsy needles in clinical settings. As a result, the biopsy needle segment is projected to witness significant growth in the coming years.

Injection Needles:

Injection needles used in endoscopic ultrasound procedures are primarily employed for therapeutic interventions, such as delivering medications directly into lesions or cysts. The rising prevalence of chronic diseases requiring targeted therapies has led to a spike in the usage of injection needles in endoscopic procedures. Additionally, the increasing adoption of endoscopic treatments that require direct intervention, such as sclerotherapy and chemotherapy injections, is propelling the market for injection needles. Innovations in injection needle technology, including improved safety features and precision delivery systems, are enhancing their appeal among healthcare providers. As minimally invasive treatment options continue to gain traction, the injection needle segment is expected to experience healthy growth in line with the overall endoscopic ultrasound market.

Cytology Needles:

Cytology needles play a vital role in the sampling processes for diagnostic purposes in endoscopic ultrasound procedures. They allow for the collection of cells from targeted organs for cytological evaluation, aiding in the diagnosis of various pathologies, especially in oncology. With the increasing focus on early detection of cancers, the demand for cytology needles is anticipated to rise. These needles are specifically designed to minimize trauma to surrounding tissues while maximizing the yield of cellular material. The growing trend towards personalized medicine and targeted therapies further fuels the need for accurate cytological assessment, which is supported by advancements in needle technology. The cytology needle segment is positioned for considerable growth as healthcare systems prioritize early intervention strategies in cancer care.

Histology Needles:

Histology needles are essential in endoscopic ultrasounds for obtaining samples that are subsequently processed for histopathological examination. These needles are designed to provide high-quality tissue samples that are critical for accurate diagnosis and treatment planning. There is a growing recognition of the importance of histological evaluation in managing various diseases, particularly cancers, which enhances the demand for histology needles. The segment is benefiting from advancements in histological techniques and the development of needles that ensure optimal tissue preservation. As the healthcare sector increasingly adopts evidence-based practices that rely on comprehensive histopathological analysis, the histology needle market is expected to expand steadily. The increasing focus on precision medicine is also anticipated to drive demand for histology needles, as clinicians seek detailed insights into disease mechanisms and pathology.

By Application

Diagnosis:

The diagnosis segment of the endoscopic ultrasound needles market plays a crucial role in the identification of various medical conditions, mainly gastrointestinal disorders and tumors. Endoscopic ultrasound offers a minimally invasive approach to obtaining tissue samples for cytological and histological evaluation. The rising prevalence of cancer, including pancreatic and esophageal cancers, necessitates accurate diagnostic capabilities, boosting the demand for endoscopic ultrasound needles. Furthermore, technological advancements in imaging and sampling techniques enhance diagnostic accuracy, making them invaluable in clinical settings. As healthcare providers increasingly recognize the importance of early diagnosis in managing diseases, the diagnostic application of endoscopic ultrasound needles is expected to experience robust growth. Investments in healthcare infrastructure, particularly in diagnostic capabilities, are also contributing to the expansion of this segment.

Therapeutics:

The therapeutic application of endoscopic ultrasound needles is gaining significant traction, primarily due to the rising trend of minimally invasive interventions. These needles are employed for various therapeutic procedures, including draining cysts, performing sclerotherapy, and administering targeted therapies directly into lesions. The demand for effective and minimally invasive treatment options is driving the adoption of endoscopic ultrasound needles in therapeutic applications. Moreover, an increasing number of patients prefer outpatient procedures that require less recovery time, further supporting the growth of this segment. The integration of innovative technologies, such as ultrasound-guided injections and real-time imaging, is enhancing the efficacy of therapeutic interventions. As healthcare professionals continue to embrace advanced techniques for managing complex conditions, the therapeutic application of endoscopic ultrasound needles is expected to witness significant growth in the foreseeable future.

By User

Hospitals:

Hospitals represent the largest end-user segment for endoscopic ultrasound needles, driven by the high volume of endoscopic procedures performed within these settings. Hospitals are equipped with advanced technology and resources necessary to carry out complex diagnostic and therapeutic procedures. The rising incidence of chronic diseases, coupled with the increasing demand for minimally invasive surgical options, is propelling the use of endoscopic ultrasound needles in hospitals. Additionally, hospitals benefit from the presence of multidisciplinary teams that can provide comprehensive care to patients requiring endoscopic interventions. The emphasis on patient safety and quality of care in hospital settings further fosters the growth of this segment. As hospitals continue to invest in cutting-edge technology and expand their endoscopic services, the demand for endoscopic ultrasound needles is expected to grow significantly.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as a significant end-user of endoscopic ultrasound needles, primarily driven by the increasing preference for outpatient surgical procedures. The growth of ASCs is attributed to their ability to provide safe, efficient, and cost-effective services. The adoption of endoscopic ultrasound techniques in ASCs is rising, as these facilities focus on delivering high-quality care without the need for prolonged hospital stays. The convenience and accessibility of ASCs are attracting patients seeking minimally invasive procedures. Furthermore, advancements in endoscopic technology are enabling ASCs to perform a wider range of procedures effectively. The ongoing trend towards outpatient care is projected to boost the demand for endoscopic ultrasound needles within ambulatory surgical centers.

Specialty Clinics:

Specialty clinics are increasingly utilizing endoscopic ultrasound needles to provide targeted services and manage specific health conditions. These clinics often focus on areas such as gastroenterology, oncology, and pain management, making them critical players in the endoscopic ultrasound market. The rising patient volume seeking specialized care drives the demand for precise diagnostic and therapeutic tools like endoscopic ultrasound needles. Moreover, specialty clinics are known for their personalized approach to patient care, which enhances the overall treatment experience. The growing number of patients diagnosed with chronic diseases requiring specialized management is further supporting the expansion of this segment. As healthcare providers continue to deliver focused care in specialty settings, the market for endoscopic ultrasound needles is expected to see significant growth.

By Size

19 Gauge:

The 19 gauge endoscopic ultrasound needles are favored for their larger lumen, which facilitates better aspiration and sample retrieval during endoscopic procedures. These needles are particularly useful in obtaining samples from larger or more complex lesions that may be difficult to assess with smaller gauge needles. The increasing prevalence of complex tumors and the demand for accurate diagnostic capabilities are driving the adoption of 19 gauge needles. Furthermore, the advancement in techniques that allow for the use of these larger needles without compromising patient safety enhances their appeal in clinical settings. The 19 gauge segment is expected to grow as healthcare professionals increasingly recognize the benefits of using larger gauge needles for specific applications, especially in oncology.

22 Gauge:

The 22 gauge endoscopic ultrasound needles are among the most commonly used needles in clinical practice due to their balance between flexibility and performance. They are suitable for a wide range of procedures, making them a versatile option for healthcare providers. The rising incidence of gastrointestinal disorders and the need for effective sampling techniques are contributing to the growth of this segment. Additionally, advancements in 22 gauge needle technology, such as improved tip designs and coatings that enhance maneuverability, are further promoting their usage. As more healthcare facilities seek to improve their diagnostic capabilities, the 22 gauge segment is anticipated to witness steady growth in the coming years.

25 Gauge:

The 25 gauge endoscopic ultrasound needles are preferred for their smaller size, which allows for minimally invasive sampling with reduced trauma to surrounding tissues. This makes them particularly suitable for delicate procedures where precision is paramount, such as in the aspiration of small lesions. The increasing focus on patient comfort and safety drives the demand for 25 gauge needles, especially in outpatient settings. Furthermore, advancements in needle technology have enhanced the performance of 25 gauge needles, making them highly effective for various applications. As the healthcare industry continues to prioritize minimally invasive techniques, the 25 gauge segment is expected to grow significantly, driven by growing awareness and preference for patient-centered care.

By Region

The North American region is anticipated to hold the largest market share in the endoscopic ultrasound needles market, driven by high healthcare expenditure and the presence of advanced healthcare infrastructure. The increasing prevalence of gastrointestinal disorders and cancers in this region significantly contributes to the demand for endoscopic ultrasound procedures. Furthermore, well-established healthcare facilities and a high rate of adoption of cutting-edge technologies play a pivotal role in market growth. It is expected that the North American market will exhibit a CAGR of 6.5% during the forecast period, reflecting the ongoing advancements in endoscopic ultrasound technology and the rising demand for minimally invasive procedures.

Europe is also expected to contribute significantly to the global endoscopic ultrasound needles market, driven by a growing aging population and increasing awareness about early diagnosis and treatment. The region is characterized by advanced healthcare systems and a high rate of acceptance of innovative medical devices. The increasing prevalence of chronic diseases and the rising number of endoscopic procedures are expected to fuel market growth in Europe. However, the market size in Europe will remain aligned with the global numbers, ensuring that the regional split does not exceed the overall market valuation. The Asia Pacific region is also witnessing rapid growth due to the increasing healthcare investments and rising awareness of advanced diagnostic techniques, making it a key player in the endoscopic ultrasound needles market.

Opportunities

The endoscopic ultrasound needles market is poised for considerable opportunities due to the ongoing advancements in medical technology. As healthcare providers increasingly seek to enhance patient outcomes and minimize complications, the demand for innovative and efficient sampling tools is on the rise. The integration of advanced imaging techniques with endoscopic ultrasound procedures is providing healthcare professionals with better visualization and precision, thereby enhancing the overall efficacy of treatments. Additionally, the growing emphasis on personalized medicine and targeted therapies creates a favorable environment for the adoption of advanced endoscopic ultrasound needles that cater to specific patient needs. With ongoing research and development efforts aimed at improving needle designs and performance, the market is expected to capitalize on these opportunities, leading to substantial growth in the coming years.

Moreover, the rising prevalence of chronic diseases worldwide presents a significant opportunity for the endoscopic ultrasound needles market. As conditions such as cancer, diabetes, and gastrointestinal disorders continue to rise, healthcare systems are increasingly adopting minimally invasive techniques for diagnosis and treatment. This trend is fostering the demand for endoscopic ultrasound needles, as they play a crucial role in both diagnostic and therapeutic applications. Additionally, emerging markets in Asia Pacific and Latin America present untapped potential, as healthcare infrastructure and access to advanced medical technologies improve. By strategically positioning themselves in these regions, companies can leverage the growing demand for advanced medical devices, further enhancing their market presence.

Threats

The endoscopic ultrasound needles market faces several threats, including stringent regulatory requirements and potential market saturation. Regulatory bodies are continuously updating guidelines and standards for medical devices, which can lead to increased compliance costs for manufacturers. Navigating these regulations can be particularly challenging for small and medium-sized enterprises, potentially limiting their market entry and expansion. Furthermore, as the market matures, the risk of saturation becomes more pronounced, leading to intensified competition among manufacturers. This competitive landscape can drive down prices, impacting profit margins and overall market dynamics. Additionally, the emergence of alternative diagnostic and therapeutic techniques may pose a threat to the growth of endoscopic ultrasound needles, as healthcare providers may opt for newer, less invasive options. Addressing these challenges will require strategic planning, innovation, and adaptation to ensure sustained growth in the market.

Another significant restrainer in the endoscopic ultrasound needles market is the high cost associated with advanced medical devices. The financial burden of purchasing and maintaining high-quality endoscopic ultrasound technology may deter some healthcare facilities, particularly in developing regions, from adopting these innovative tools. This can lead to disparities in access to advanced medical technologies, hampering overall market growth. Moreover, the skilled personnel required to operate endoscopic ultrasound systems and interpret the results may not be readily available in all healthcare settings, further impeding the widespread adoption of these devices. Addressing these barriers through training programs and financial support initiatives will be crucial for fostering growth and ensuring equitable access to endoscopic ultrasound technologies.

Competitor Outlook

• Boston Scientific Corporation
• Medtronic plc
• Cook Medical LLC
• Olympus Corporation
• Ethicon, Inc.
• Conmed Corporation
• Hologic, Inc.
• Smith & Nephew plc
• Fujifilm Holdings Corporation
• Stryker Corporation
• Johnson & Johnson
• Terumo Corporation
• Karl Storz SE & Co. KG
• Medline Industries, Inc.
• Circle Cardiovascular Imaging Inc.

The competitive landscape of the endoscopic ultrasound needles market is characterized by the presence of numerous established players and emerging companies striving to enhance their market positions through innovative product offerings and strategic collaborations. Major companies are increasingly engaging in research and development activities to develop cutting-edge technologies that improve the performance and safety of endoscopic ultrasound needles. Additionally, these companies are focusing on expanding their product portfolios to cater to the diverse needs of healthcare providers and patients. The competitive intensity is expected to increase as companies strive to differentiate themselves by leveraging advanced technologies and enhancing customer service offerings.

Boston Scientific Corporation, a key player in the endoscopic ultrasound needles market, is renowned for its commitment to innovation, investing significantly in research and development. The company offers a comprehensive range of endoscopic ultrasound products, including specialized needle systems that cater to varying clinical needs. Similarly, Medtronic plc has established itself as a leader in the market through its advanced medical devices that prioritize patient outcomes and safety. The company is constantly exploring new technologies and partnerships to enhance its product offerings. Cook Medical LLC, another strong competitor, focuses on providing high-quality endoscopic ultrasound needles that meet the evolving demands of healthcare providers. Their product development initiatives are driven by an understanding of clinician needs and the latest advancements in medical technology.

Olympus Corporation is also a notable player in the endoscopic ultrasound needles market, leveraging its expertise in endoscopic technologies to deliver innovative solutions. The company's dedication to quality and performance has enabled it to maintain a strong market presence. Ethicon, Inc., part of Johnson & Johnson, is recognized for its focus on surgical excellence and has developed endoscopic ultrasound needles that prioritize safety and effectiveness. As competition intensifies, these companies, along with others in the market, are expected to engage in strategic partnerships, collaborations, and mergers to enhance their capabilities and expand their market share.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Ethicon, Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Hologic, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cook Medical LLC
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Johnson & Johnson
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Conmed Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Smith & Nephew plc
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Olympus Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Stryker Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Karl Storz SE & Co. KG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Medline Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fujifilm Holdings Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Circle Cardiovascular Imaging Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Endoscopic Ultrasound Needles Market, By Size
    • 6.1.1 19 Gauge
    • 6.1.2 22 Gauge
    • 6.1.3 25 Gauge
    • 6.1.4 25 Gauge
  • 6.2 Endoscopic Ultrasound Needles Market, By User
    • 6.2.1 Hospitals
    • 6.2.2 Ambulatory Surgical Centers
    • 6.2.3 Specialty Clinics
  • 6.3 Endoscopic Ultrasound Needles Market, By Application
    • 6.3.1 Diagnosis
    • 6.3.2 Therapeutics
  • 6.4 Endoscopic Ultrasound Needles Market, By Product Type
    • 6.4.1 Fine Aspiration Needles
    • 6.4.2 Biopsy Needles
    • 6.4.3 Injection Needles
    • 6.4.4 Cytology Needles
    • 6.4.5 Histology Needles

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Endoscopic Ultrasound Needles Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Endoscopic Ultrasound Needles market is categorized based on

By Product Type

• Fine Aspiration Needles
• Biopsy Needles
• Injection Needles
• Cytology Needles
• Histology Needles

By Application

• Diagnosis
• Therapeutics

By User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Size

• 19 Gauge
• 22 Gauge
• 25 Gauge
• 25 Gauge

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Medtronic plc
• Cook Medical LLC
• Olympus Corporation
• Ethicon, Inc.
• Conmed Corporation
• Hologic, Inc.
• Smith & Nephew plc
• Fujifilm Holdings Corporation
• Stryker Corporation
• Johnson & Johnson
• Terumo Corporation
• Karl Storz SE & Co. KG
• Medline Industries, Inc.
• Circle Cardiovascular Imaging Inc.